Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

10/04/2019 10th Anniversary of the MELiSSA Pilot Plant: travelling to Mars is in progress near the Barcelona Synchrotron Park 25/03/2019 Barcelona Synchrotron Park Sponsors the 9th Ideas Generation Program 08/03/2019 The Barcelona Synchrotron Park aims to host a university residence 01/03/2019 Delegates of the Mobile World Congress discover the park 22/02/2019 Hub b30 takes off 16/02/2019 SENER: wind, sun and moon
4 5 6 7 8 9 10 11 12 13 14